BPC-157

What is BPC-157

BPC-157 is a 15-amino acid pentadecapeptide, representing the active fragment of the BPC complex found in human gastric juice. It exhibits chemical stability, resists enzymatic degradation, and retains biological activity after oral administration. It promotes wound healing, protects gastrointestinal mucosa, and provides neuroprotection. Its structure consists of glycine-glutamic acid-proline -Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

BPC-157 Benefits

Promotes Tissue Repair and Regeneration

Studies indicate BPC-157 accelerates healing of muscle and ligament injuries, enhances tendon stiffness and elasticity, and promotes wound healing.

Gastrointestinal Protection

Research indicates BPC-157 improves gastric blood circulation, promotes healing of gastric ulcers and intestinal fistulas, protects the intestinal mucosal barrier, and alleviates symptoms associated with Crohn’s disease and irritable bowel syndrome.

Neuroprotective Effects

Research indicates BPC-157 reduces neuroinflammation and neuronal death following brain injuries (e.g., stroke, traumatic brain injury) and exhibits reparative effects on spinal cord injuries (animal studies demonstrate promotion of axonal regeneration and improved functional recovery).

BPC-157 Dosage

• Injection Dosage: Typically calculated by body weight, generally administered twice daily at 150-375 micrograms (mcg) per dose.
• Oral Dosage: Generally 100-500 micrograms (mcg) per dose, taken 1-2 times daily. Primarily used for injury recovery, inflammation management, and general tissue healing.
• Dosage Cycle: Some healthcare practitioners recommend cyclical use: administer for 6-12 weeks, followed by a 4-8 week break before resuming.

BPC157 Side Effects

Well-tolerated in animal studies with mild side effects (e.g., injection site discomfort, transient nausea).
Seek immediate medical attention if severe side effects occur.